{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:06:40Z","timestamp":1792631200986,"version":"4.5.0"},"reference-count":34,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The associations between immune-related conditions and multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS) have previously been investigated with inconsistent results. In a large population-based study, we identified 19 112 patients with MM, 5403 patients with MGUS, 96 617 matched control subjects, and 262 931 first-degree relatives. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) for the association of MM and MGUS with immune-related conditions by use of logistic regression. A personal history of all infections combined was associated with a significantly increased risk of MM (OR = 1.2; 95% CI, 1.1-1.3), and a personal history of all conditions in the categories infections (OR = 1.6; 95% CI, 1.5-1.7), inflammatory conditions (OR = 1.4; 95% CI, 1.2-1.5), and autoimmune diseases (OR = 2.1; 95% CI, 1.9-2.4) was associated with a significantly increased risk of MGUS. Several specific immune-related conditions elevated the risk of MM and\/or MGUS. A family history of autoimmune disease was associated with a significantly increased risk of MGUS (OR = 1.1; 95% CI, 1.00-1.2), but not MM. Our findings suggest that immune-related conditions and\/or their treatment are of importance in the etiology of MGUS and possibly MM. The association of both personal and family history of autoimmune disease with MGUS indicates the potential for shared susceptibility for these conditions.<\/jats:p>","DOI":"10.1182\/blood-2011-04-347559","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T03:05:49Z","timestamp":1318561549000},"page":"6284-6291","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":82,"title":["Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study"],"prefix":"10.1182","volume":"118","author":[{"given":"Ebba K.","family":"Lindqvist","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn R.","family":"Goldin","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden;"},{"name":"Center for Cancer Research, NCI, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Blimark","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf-Henrik","family":"Mellqvist","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Turesson","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sk\u00e5ne University Hospital, Malm\u00f6, Sweden; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wahlin","sequence":"additional","affiliation":[{"name":"Cancer Centre, Section of Hematology, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur Y.","family":"Kristinsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111809244480100_B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlov","year":"2008","edition":"4th ed"},{"issue":"1","key":"2019111809244480100_B2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma.","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"2019111809244480100_B3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111809244480100_B4","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"22","key":"2019111809244480100_B5","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients.","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111809244480100_B6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2008-12-192575","article-title":"Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.","volume":"114","author":"Vachon","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111809244480100_B7","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/ijc.21745","article-title":"Familial characteristics of autoimmune and hematologic disorders in 8406 multiple myeloma patients: a population-based case-control study.","volume":"118","author":"Landgren","year":"2006","journal-title":"Int J Cancer"},{"issue":"4","key":"2019111809244480100_B8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","article-title":"Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.","volume":"114","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2019111809244480100_B9","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.24514","article-title":"Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.","volume":"125","author":"Kristinsson","year":"2009","journal-title":"Int J Cancer"},{"issue":"10","key":"2019111809244480100_B10","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/leu.2009.134","article-title":"Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis.","volume":"23","author":"Landgren","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"2019111809244480100_B11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"25","key":"2019111809244480100_B12","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","article-title":"Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study.","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"13","key":"2019111809244480100_B13","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"2019111809244480100_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.22719","article-title":"The non-Hodgkin lymphomas: a review of the epidemiologic literature.","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"issue":"17","key":"2019111809244480100_B15","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ejca.2006.04.021","article-title":"Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden.","volume":"42","author":"Soderberg","year":"2006","journal-title":"Eur J Cancer"},{"issue":"2","key":"2019111809244480100_B16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"issue":"7","key":"2019111809244480100_B17","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2019111809244480100_B18","first-page":"1697","article-title":"Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia.","volume":"91","author":"Landgren","year":"2006","journal-title":"Haematologica"},{"issue":"11","key":"2019111809244480100_B19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1034\/j.1600-0463.2001.d01-149.x","article-title":"Multiple myeloma following an episode of community-acquired pneumococcal bacteraemia or meningitis.","volume":"109","author":"Gregersen","year":"2001","journal-title":"APMIS"},{"key":"2019111809244480100_B20","volume-title":"Svenska cancerregistret","author":"Swedish National Board of Health","year":"2008"},{"issue":"10","key":"2019111809244480100_B21","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.22912","article-title":"Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.","volume":"121","author":"Turesson","year":"2007","journal-title":"Int J Cancer"},{"issue":"7","key":"2019111809244480100_B22","first-page":"598","article-title":"Slutenv\u00e5rdsregistrets tillf\u00f6rlitlighet.","volume":"91","author":"Nilsson","year":"1994","journal-title":"L\u00e4kartidningen"},{"key":"2019111809244480100_B23","volume-title":"Patientregistret","author":"Swedish National Board of Health","year":"2008"},{"key":"2019111809244480100_B24","volume-title":"Flergenerationsregistret","author":"Skarle","year":"2008"},{"issue":"8","key":"2019111809244480100_B25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jnci\/djq043","article-title":"Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.","volume":"102","author":"Kristinsson","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"2019111809244480100_B26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2019111809244480100_B27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/ard.2005.036459","article-title":"Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica\/giant cell arteritis.","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2019111809244480100_B28","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk.","volume":"32A","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"issue":"3","key":"2019111809244480100_B29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions.","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"issue":"11","key":"2019111809244480100_B30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0021-9681(78)90071-1","article-title":"Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.","volume":"31","author":"Isomaki","year":"1978","journal-title":"J Chronic Dis"},{"issue":"1","key":"2019111809244480100_B31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/03009742.2010.493895","article-title":"Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009.","volume":"40","author":"Neovius","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"2019111809244480100_B32","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report.","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"2019111809244480100_B33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","article-title":"Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma.","volume":"106","author":"Bergsagel","year":"2005","journal-title":"Blood"},{"issue":"8787","key":"2019111809244480100_B34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0140-6736(92)90004-M","article-title":"Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis: the Medical Research Council Working Party for Leukaemia in Adults.","volume":"339","author":"MacLennan","year":"1992","journal-title":"Lancet"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6284\/1343412\/zh805011006284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6284\/1343412\/zh805011006284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:24:25Z","timestamp":1639171465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/24\/6284\/29206\/Personal-and-family-history-of-immunerelated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,8]]},"references-count":34,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2011,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-347559","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,8]]}}}